5.3218
price down icon8.48%   -0.5182
 
loading
Schlusskurs vom Vortag:
$5.84
Offen:
$5.85
24-Stunden-Volumen:
2.27M
Relative Volume:
0.38
Marktkapitalisierung:
$1.15B
Einnahmen:
$2.59M
Nettoeinkommen (Verlust:
$-137.89M
KGV:
-6.5701
EPS:
-0.81
Netto-Cashflow:
$-69.76M
1W Leistung:
-14.07%
1M Leistung:
+2.20%
6M Leistung:
+256.33%
1J Leistung:
+394.91%
1-Tages-Spanne:
Value
$5.31
$5.86
1-Wochen-Bereich:
Value
$5.31
$6.16
52-Wochen-Spanne:
Value
$1.05
$6.75

Atai Life Sciences N V Stock (ATAI) Company Profile

Name
Firmenname
Atai Life Sciences N V
Name
Telefon
49 89 2153 9035
Name
Adresse
PROF. J.H. BAVINCKLAAN 7, AMSTELVEEN
Name
Mitarbeiter
54
Name
Twitter
Name
Nächster Verdiensttermin
2024-12-11
Name
Neueste SEC-Einreichungen
Name
ATAI's Discussions on Twitter

Vergleichen Sie ATAI mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ATAI
Atai Life Sciences N V
5.345 1.56B 2.59M -137.89M -69.76M -0.81
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
420.04 109.11B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
629.60 68.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
432.37 60.25B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
811.55 50.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
179.87 40.44B 447.02M -1.18B -868.57M -6.1812

Atai Life Sciences N V Stock (ATAI) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-10-13 Eingeleitet Needham Buy
2025-07-29 Eingeleitet Oppenheimer Outperform
2024-11-18 Bestätigt H.C. Wainwright Buy
2024-04-03 Hochstufung Maxim Group Hold → Buy
2022-11-01 Eingeleitet Loop Capital Buy
2021-11-30 Eingeleitet Maxim Group Buy
2021-11-11 Eingeleitet ROTH Capital Buy
2021-10-18 Eingeleitet H.C. Wainwright Buy
2021-09-01 Eingeleitet Jefferies Buy
2021-07-13 Eingeleitet Berenberg Buy
2021-07-13 Eingeleitet Canaccord Genuity Buy
2021-07-13 Eingeleitet Cantor Fitzgerald Buy
2021-07-13 Eingeleitet Citigroup Buy
2021-07-13 Eingeleitet Cowen Outperform
2021-07-13 Eingeleitet Credit Suisse Outperform
2021-07-13 Eingeleitet RBC Capital Mkts Sector Perform
2021-07-08 Eingeleitet Aegis Capital Buy
Alle ansehen

Atai Life Sciences N V Aktie (ATAI) Neueste Nachrichten

pulisher
07:02 AM

Is Atai Life Sciences NV a good long term investmentSmall Cap Stock Opportunities & High Yield Trading Signals - earlytimes.in

07:02 AM
pulisher
04:51 AM

Is Atai Life Sciences N.V. stock a defensive play in 2025Analyst Upgrade & Scalable Portfolio Growth Methods - newser.com

04:51 AM
pulisher
04:39 AM

Is Atai Life Sciences N.V. stock poised for growth2025 Analyst Calls & Weekly Watchlist of Top Performers - newser.com

04:39 AM
pulisher
04:02 AM

Published on: 2025-11-03 03:02:35 - newser.com

04:02 AM
pulisher
Nov 02, 2025

Why analysts recommend Atai Life Sciences N.V. (9VC) stockEarnings Risk Summary & Safe Entry Zone Tips - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Will Atai Life Sciences N.V. stock reach all time highs in 2025Market Trend Report & Safe Capital Growth Tips - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Will Atai Life Sciences N.V. stock sustain high P E ratiosWeekly Profit Analysis & Growth Focused Investment Plans - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Why Atai Life Sciences N.V. (9VC) stock appears on watchlistsJuly 2025 Volume & Fast Moving Market Watchlists - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Ranking Atai Life Sciences N.V. among high performing stocks via tools2025 Dividend Review & Risk Managed Investment Strategies - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Is Atai Life Sciences N.V. (9VC) stock nearing a technical breakoutMarket Performance Summary & AI Powered Market Trend Analysis - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Will Atai Life Sciences N.V. (9VC) stock justify high valuationMarket Trend Review & Free Daily Entry Point Trade Alerts - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Published on: 2025-11-01 04:43:33 - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Will Atai Life Sciences N.V. (9VC) stock test record highs in 2025Portfolio Performance Report & AI Forecast Swing Trade Picks - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Why Atai Life Sciences N.V. stock appeals to dividend seekersJuly 2025 PreEarnings & Real-Time Buy Zone Alerts - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Understanding Atai Life Sciences N.V.’s price movement2025 Technical Overview & Low Drawdown Investment Strategies - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Will Atai Life Sciences N.V. (9VC) stock outperform energy sector in 2025July 2025 Sector Moves & Community Consensus Trade Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Can Atai Life Sciences N.V. stock resist sector downturns2025 Retail Activity & High Accuracy Trade Signal Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Atai Life Sciences N.V. stock trend forecastTrade Volume Summary & Fast Moving Market Watchlists - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Chart based analysis of Atai Life Sciences N.V. trendsProfit Target & Step-by-Step Trade Execution Guides - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Published on: 2025-10-30 23:24:14 - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

Combining machine learning predictions for Atai Life Sciences N.V.Quarterly Growth Report & Capital Efficient Trade Techniques - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Building trade automation scripts for Atai Life Sciences N.V.Earnings Miss & Risk Managed Trade Strategies - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

Can machine learning forecast Atai Life Sciences N.V. recovery2025 Market Overview & Risk Managed Trade Strategies - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

Why Atai Life Sciences N.V. stock attracts high net worth investorsEarnings Summary Report & AI Enhanced Trading Signals - fcp.pa.gov.br

Oct 28, 2025
pulisher
Oct 28, 2025

Is Atai Life Sciences N.V. stock recession proof2025 Earnings Impact & AI Based Buy/Sell Signal Reports - fcp.pa.gov.br

Oct 28, 2025

Finanzdaten der Atai Life Sciences N V-Aktie (ATAI)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$37.24
price down icon 0.66%
$92.24
price down icon 1.13%
$28.82
price up icon 0.84%
$103.50
price down icon 0.45%
biotechnology ONC
$311.64
price up icon 0.32%
$181.29
price down icon 4.26%
Kapitalisierung:     |  Volumen (24h):